These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35607815)

  • 1. Higher In Vivo Fecal Concentrations of Clostridioides difficile Toxins A and B in Patients With North American Pulsed-Field Gel Electrophoresis Type 1/Ribotype 027 Strain Infection.
    Alonso CD; Pollock NR; Garey KW; Gonzales-Luna AJ; Williams DN; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Kelly CP
    Clin Infect Dis; 2022 Nov; 75(11):2019-2022. PubMed ID: 35607815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Clostridium difficile ribotype 027 in Korea.
    Kim H; Lee Y; Moon HW; Lim CS; Lee K; Chong Y
    Korean J Lab Med; 2011 Jul; 31(3):191-6. PubMed ID: 21779194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
    Sirard S; Valiquette L; Fortier LC
    J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
    Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
    Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.
    Wroblewski D; Hannett GE; Bopp DJ; Dumyati GK; Halse TA; Dumas NB; Musser KA
    J Clin Microbiol; 2009 Jul; 47(7):2142-8. PubMed ID: 19403775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.
    van den Berg RJ; Claas EC; Oyib DH; Klaassen CH; Dijkshoorn L; Brazier JS; Kuijper EJ
    J Clin Microbiol; 2004 Mar; 42(3):1035-41. PubMed ID: 15004050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.
    Anjuwon-Foster BR; Maldonado-Vazquez N; Tamayo R
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735765
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.
    Pituch H; van den Braak N; van Leeuwen W; van Belkum A; Martirosian G; Obuch-Woszczatyński P; Łuczak M; Meisel-Mikołajczyk F
    Clin Microbiol Infect; 2001 Aug; 7(8):442-6. PubMed ID: 11591209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples.
    van Rossen TM; van Prehn J; Koek A; Jonges M; van Houdt R; van Mansfeld R; Kuijper EJ; Vandenbroucke-Grauls CMJE; Budding AE
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):23. PubMed ID: 33514422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
    Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
    Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
    Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC
    Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
    Boone JH; Archbald-Pannone LR; Wickham KN; Carman RJ; Guerrant RL; Franck CT; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1045-51. PubMed ID: 24449345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains.
    Kristjánsson M; Samore MH; Gerding DN; DeGirolami PC; Bettin KM; Karchmer AW; Arbeit RD
    J Clin Microbiol; 1994 Aug; 32(8):1963-9. PubMed ID: 7989550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.